Access Programs for Peginterferon alfa-2a
Drug Company Assistance
The Genentech Access to Care Foundation (GATCF) helps patients who are uninsured or have been denied coverage access peginterferon alfa-2a either for free or at reduced cost. To be eligible, a patient must either have been denied coverage or have no insurance, have an annual adjusted household income of less than $100,000, and meet certain medical criteria.
Applying for the GATCF requires a few steps. First, the healthcare provider must complete the statement of medical necessity form and the patient authorization and notice of release of information form. These forms can be submitted through the My Patient Solutions portal, or they can be faxed to 1-888-929-3334. After the forms are received, a representative will contact the patient to verify their financial circumstances. If you have questions, please call 1-888-249-4918, Monday through Friday from 6:00 AM to 5:00 PM PST.
Some patients with insurance may also qualify for the Genentech Copay Card. To check eligibility or enroll in the program, please call 1-888-202-9939.
Foundation Assistance
The Patient Access Network Foundation also offers co-pay assistance for patients needing peginterferon alfa-2a. Please read the application instructions, and then follow the prompts on the online application.
Help ASH Build an Inclusive Hematology Community!
ASH is committed to building and nurturing a global hematology community and workforce inclusive of diverse perspectives, talents, and experiences as it works toward one collective goal: helping hematologists conquer blood diseases worldwide.
How Can You Help?
Visit your My Account page, make needed updates to your demographic details, and select your preferred level of ASH access to your information; aggregated or individually identifiable, or choose not to provide or share your information. By sharing information about who you are, you will help ASH have a better appreciation of the diverse needs and talents present in the field, and help to build a more inclusive, collaborative hematology community. It will take only a few moments to complete!
Update Access to Demographic Information Learn About Our Mission